240 related articles for article (PubMed ID: 19645781)
1. Significance of periductal lymphatic and blood vascular densities in intraductal carcinoma of the breast.
El-Gohary YM; Metwally G; Saad RS; Robinson MJ; Mesko T; Poppiti RJ
Breast J; 2009; 15(3):261-7. PubMed ID: 19645781
[TBL] [Abstract][Full Text] [Related]
2. Prognostic significance of intratumoral and peritumoral lymphatic density and blood vessel density in invasive breast carcinomas.
El-Gohary YM; Metwally G; Saad RS; Robinson MJ; Mesko T; Poppiti RJ
Am J Clin Pathol; 2008 Apr; 129(4):578-86. PubMed ID: 18343785
[TBL] [Abstract][Full Text] [Related]
3. Lymphatic vessel density as prognostic marker in esophageal adenocarcinoma.
Saad RS; Lindner JL; Liu Y; Silverman JF
Am J Clin Pathol; 2009 Jan; 131(1):92-8. PubMed ID: 19095571
[TBL] [Abstract][Full Text] [Related]
4. Lymphatic vessel density as a prognostic marker in clinical stage I endocervical adenocarcinoma.
Saad RS; Ismiil N; Ghorab Z; Nofech-Mozes S; Dubé V; Covens A; Khalifa MA
Int J Gynecol Pathol; 2010 Jul; 29(4):386-93. PubMed ID: 20567154
[TBL] [Abstract][Full Text] [Related]
5. Microvessel and lymphatic density in tubular carcinoma of the breast: comparative study with invasive low-grade ductal carcinoma.
Fernandez-Aguilar S; Jondet M; Simonart T; Nöel JC
Breast; 2006 Dec; 15(6):782-5. PubMed ID: 16931017
[TBL] [Abstract][Full Text] [Related]
6. Accurate assessment of lymph vessel tumor emboli in invasive ductal carcinoma of the breast according to tumor areas, and their prognostic significance.
Yamauchi C; Hasebe T; Iwasaki M; Imoto S; Wada N; Fukayama M; Ochiai A
Hum Pathol; 2007 Feb; 38(2):247-59. PubMed ID: 17056095
[TBL] [Abstract][Full Text] [Related]
7. An immunohistochemical analysis of angiogenesis in invasive breast cancer with correlations to clinicopathologic predictors.
Nakopoulou L; Lekkas N; Lazaris AC; Athanassiadou P; Giannopoulou I; Mavrommatis J; Davaris P
Anticancer Res; 1999; 19(5C):4547-53. PubMed ID: 10650809
[TBL] [Abstract][Full Text] [Related]
8. Prognostic significance of lymphovascular invasion diagnosed by lymphatic endothelium immunostaining in breast cancer patients.
Tezuka K; Onoda N; Takashima T; Takagaki K; Ishikawa T; Wakasa T; Wakasa K; Hirakawa K
Oncol Rep; 2007 May; 17(5):997-1003. PubMed ID: 17390035
[TBL] [Abstract][Full Text] [Related]
9. Correlation of cyclooxygenase-2 and aromatase immunohistochemical expression in invasive ductal carcinoma, ductal carcinoma in situ, and adjacent normal epithelium.
Oliveira VM; Piato S; Silva MA
Breast Cancer Res Treat; 2006 Feb; 95(3):235-41. PubMed ID: 16322898
[TBL] [Abstract][Full Text] [Related]
10. Expression of CD31 by cells of extensive ductal in situ and invasive carcinomas of the breast.
Sapino A; Bongiovanni M; Cassoni P; Righi L; Arisio R; Deaglio S; Malavasi F
J Pathol; 2001 Jun; 194(2):254-61. PubMed ID: 11400156
[TBL] [Abstract][Full Text] [Related]
11. Improved methods of detection of lymphovascular invasion demonstrate that it is the predominant method of vascular invasion in breast cancer and has important clinical consequences.
Mohammed RA; Martin SG; Gill MS; Green AR; Paish EC; Ellis IO
Am J Surg Pathol; 2007 Dec; 31(12):1825-33. PubMed ID: 18043036
[TBL] [Abstract][Full Text] [Related]
12. [Expressions of D2-40 and CD34 in invasive ductal carcinoma of the breast and the clinical implications].
Zhen LF; Ye CS; Liu MF; Ding GP; Liao JJ
Nan Fang Yi Ke Da Xue Xue Bao; 2010 Jul; 30(7):1548-51. PubMed ID: 20650763
[TBL] [Abstract][Full Text] [Related]
13. Immunophenotype of intraductal carcinoma.
Bose S; Lesser ML; Norton L; Rosen PP
Arch Pathol Lab Med; 1996 Jan; 120(1):81-5. PubMed ID: 8554451
[TBL] [Abstract][Full Text] [Related]
14. Increased expression of CD146 and microvessel density (MVD) in invasive micropapillary carcinoma of the breast: Comparative study with invasive ductal carcinoma-not otherwise specified.
Li W; Yang D; Wang S; Guo X; Lang R; Fan Y; Gu F; Zhang X; Niu Y; Yan X; Fu L
Pathol Res Pract; 2011 Dec; 207(12):739-46. PubMed ID: 22051146
[TBL] [Abstract][Full Text] [Related]
15. Does thymidine phosphorylase correlate with angiogenesis in intraductal carcinoma of the breast?
Erkus M; Meteoglu I; Culhaci N; Meydan N; Erdogdu I
Saudi Med J; 2006 Sep; 27(9):1329-33. PubMed ID: 16951768
[TBL] [Abstract][Full Text] [Related]
16. Follicular thyroid carcinoma invades venous rather than lymphatic vessels.
Lin X; Zhu B; Liu Y; Silverman JF
Diagn Pathol; 2010 Jan; 5():8. PubMed ID: 20205756
[TBL] [Abstract][Full Text] [Related]
17. Angiogenesis as determined by computerised image analysis and the risk of early relapse in women with invasive ductal breast carcinoma.
Olewniczak S; Chosia M; Kołodziej B; Kwas A; Kram A; Domagała W
Pol J Pathol; 2003; 54(1):53-9. PubMed ID: 12817881
[TBL] [Abstract][Full Text] [Related]
18. D2-40 expression by breast myoepithelium: potential pitfalls in distinguishing intralymphatic carcinoma from in situ carcinoma.
Rabban JT; Chen YY
Hum Pathol; 2008 Feb; 39(2):175-83. PubMed ID: 18206495
[TBL] [Abstract][Full Text] [Related]
19. Lymphatic microvessel density as prognostic marker in colorectal cancer.
Saad RS; Kordunsky L; Liu YL; Denning KL; Kandil HA; Silverman JF
Mod Pathol; 2006 Oct; 19(10):1317-23. PubMed ID: 16799477
[TBL] [Abstract][Full Text] [Related]
20. Prognostic significance of oncogenic markers in ductal carcinoma in situ of the breast: a clinicopathologic study.
Altintas S; Lambein K; Huizing MT; Braems G; Asjoe FT; Hellemans H; Van Marck E; Weyler J; Praet M; Van den Broecke R; Vermorken JB; Tjalma WA
Breast J; 2009; 15(2):120-32. PubMed ID: 19292797
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
